المؤلفون: Sepe P., Martinetti A., Mennitto A., Verzoni E., Claps M., Raimondi A., Sottotetti E., Grassi P., Guadalupi V., Stellato M., Zattarin E., Di Maio M., Procopio G.

المساهمون: Sepe P., Martinetti A., Mennitto A., Verzoni E., Claps M., Raimondi A., Sottotetti E., Grassi P., Guadalupi V., Stellato M., Zattarin E., Di Maio M., Procopio G.

مصطلحات موضوعية: circulating angiogenic factor, circulating biomarker, pazopanib, renal cell carcinoma, TKI, Aged, Angiogenesis Inhibitor, Antineoplastic Agent, Carcinoma, Renal Cell, Chemokine CXCL12, Disease Progression, E-Selectin, Female, Hepatocyte Growth Factor, Human, Interleukin-6, Interleukin-8, Kidney Neoplasm, Male, Middle Aged, Osteopontin, Progression-Free Survival, Prospective Studie, Pyrimidine, Response Evaluation Criteria in Solid Tumor, Sulfonamide, Survival Rate, Translational Medical Research, Vascular Endothelial Growth Factor A

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32889831; info:eu-repo/semantics/altIdentifier/wos/WOS:000570127200003; volume:43; issue:9; firstpage:621; lastpage:627; numberofpages:7; journal:AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS; http://hdl.handle.net/2318/1770062Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85085770569

الإتاحة: https://doi.org/10.1097/COC.0000000000000719Test
http://hdl.handle.net/2318/1770062Test

المؤلفون: M. Di Salvatore, F. Pietrantonio, A. Orlandi, M. Del Re, R. Berenato, E. Rossi, M. Caporale, D. Guarino, A. Martinetti, M. Basso, R. Mennitto, C. Santonocito, A. Mennitto, G. Schinzari, I. Bossi, E. Capoluongo, R. Danesi, F. de Braud, C. Barone

المساهمون: M. Di Salvatore, F. Pietrantonio, A. Orlandi, M. Del Re, R. Berenato, E. Rossi, M. Caporale, D. Guarino, A. Martinetti, M. Basso, R. Mennitto, C. Santonocito, A. Mennitto, G. Schinzari, I. Bossi, E. Capoluongo, R. Danesi, F. de Braud, C. Barone

مصطلحات موضوعية: Bevacizumab, colorectal cancer, ENOS, IL-8, single nucleotid polymorphism, aged, angiogenesis inhibitor, antineoplastic combined chemotherapy Protocol, cohort studie, colorectal neoplasm, female, Fluorouracil, human, Interleukin-8, Leucovorin, male, mutation, neoplasm metastasi, nitric oxide synthase type III, organoplatinum compound, polymorphism, single nucleotide, treatment outcome, ras protein, oncology, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28129643; info:eu-repo/semantics/altIdentifier/wos/WOS:000396024600063; volume:8; issue:10; firstpage:16887; lastpage:16898; numberofpages:12; journal:ONCOTARGET; http://hdl.handle.net/2434/552428Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85014699212

الإتاحة: https://doi.org/10.18632/oncotarget.14810Test
http://hdl.handle.net/2434/552428Test

المؤلفون: Massimo Di Maio, Marco Stellato, Alessia Mennitto, Elena Verzoni, Paolo Grassi, Valentina Guadalupi, Elisa Sottotetti, Alessandra Raimondi, Giuseppe Procopio, Melanie Claps, Pierangela Sepe, Emma Zattarin, Antonia Martinetti

المصدر: American Journal of Clinical Oncology. 43:621-627

مصطلحات موضوعية: Male, Vascular Endothelial Growth Factor A, Oncology, Cancer Research, circulating angiogenic factors, Drug Resistance, Angiogenesis Inhibitors, Translational Research, Biomedical, 0302 clinical medicine, Renal cell carcinoma, pazopanib, Prospective Studies, 030212 general & internal medicine, Osteopontin, Prospective cohort study, Translational Medical Research, Sulfonamides, biology, Hepatocyte Growth Factor, circulating biomarkers, Middle Aged, TKI, Kidney Neoplasms, Progression-Free Survival, Survival Rate, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Disease Progression, Female, E-Selectin, medicine.drug, renal cell carcinoma, medicine.medical_specialty, Indazoles, Antineoplastic Agents, Aged, Carcinoma, Renal Cell, Chemokine CXCL12, Humans, Interleukin-6, Interleukin-8, Pyrimidines, Drug Resistance, Neoplasm, Pazopanib, 03 medical and health sciences, Internal medicine, Carcinoma, medicine, Progression-free survival, Survival rate, business.industry, Renal Cell, medicine.disease, biology.protein, Neoplasm, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0893db53ea30508768aa8057e6975a1aTest
https://doi.org/10.1097/coc.0000000000000719Test

المؤلفون: Luigi Celio, Claudia Maggi, Giulia Bianchi, Monica Milano, Maria Silvia Cona, Claudio Vernieri, Gabriella Mariani, Marta Brambilla, Alessia Mennitto, Chiara Fabbroni, Elena Farè, Michele Prisciandaro, Filippo de Braud, Sara Cresta, Giuseppe Capri

المصدر: Clinical Breast Cancer. 19:e306-e318

مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Antineoplastic Agents, Breast Neoplasms, Kaplan-Meier Estimate, Deoxycytidine, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Breast cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Progression-free survival, Adverse effect, neoplasms, Aged, Proportional Hazards Models, Retrospective Studies, Aged, 80 and over, Chemotherapy, business.industry, Cancer, Middle Aged, Prognosis, medicine.disease, Gemcitabine, Metastatic breast cancer, Treatment Outcome, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9150c3958945ff554cab1232c40520d1Test
https://doi.org/10.1016/j.clbc.2018.12.004Test

المؤلفون: Sarah Scagliarini, Michele Prisciandaro, Roberto Sabbatini, Giorgia Peverelli, Roberto Iacovelli, Giuseppe Procopio, Alessia Mennitto, Salvatore Caponnetto, Gaetano Facchini, Claudia Caserta, Giuseppe Fornarini, Elena Verzoni, Francesco Massari, Ugo De Giorgi, Raffaele Ratta

المصدر: American Journal of Clinical Oncology. 42:42-45

مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Disease free survival, genetic structures, Cabozantinib, Pyridines, Treatment outcome, Administration, Oral, urologic and male genital diseases, Disease-Free Survival, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Renal cell carcinoma, Internal medicine, Carcinoma, Humans, Medicine, Anilides, 030212 general & internal medicine, Carcinoma, Renal Cell, Aged, business.industry, Middle Aged, medicine.disease, Kidney Neoplasms, Clinical trial, Treatment Outcome, chemistry, Multicenter study, 030220 oncology & carcinogenesis, Female, business, Real world data

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d34b7bd47a4ac39592d86a1c21e4adcTest
https://doi.org/10.1097/coc.0000000000000478Test

المؤلفون: Ettore Capoluongo, Ilaria Bossi, Alessia Mennitto, Concetta Santonocito, Filippo de Braud, Romano Danesi, Roberta Mennitto, Rosa Berenato, Giovanni Schinzari, Ernesto Rossi, Carlo Barone, Donatella Guarino, Mariantonietta Di Salvatore, Marzia Del Re, Marta Caporale, Filippo Pietrantonio, Michele Basso, Antonia Martinetti, Armando Orlandi

المساهمون: Di Salvatore, M, Pietrantonio, F, Orlandi, A, Del Re, M, Berenato, R, Rossi, E, Caporale, M, Guarino, D, Martinetti, A, Basso, M, Mennitto, R, Santonocito, C, Mennitto, A, Schinzari, G, Bossi, I, Capoluongo, E, Danesi, R, de Braud, F, Barone, C

المصدر: Oncotarget

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Pathology, Organoplatinum Compounds, Colorectal cancer, medicine.medical_treatment, Leucovorin, Angiogenesis Inhibitors, law.invention, Cohort Studies, Single nucleotid polymorphism, 0302 clinical medicine, Settore BIO/12 - BIOCHIMICA CLINICA E BIOLOGIA MOLECOLARE CLINICA, law, Enos, Genotype, Antineoplastic Combined Chemotherapy Protocols, Medicine, Neoplasm Metastasis, Clinical pharmacology, biology, ENOS, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Fluorouracil, Colorectal Neoplasms, medicine.drug, Research Paper, medicine.medical_specialty, Bevacizumab, Nitric Oxide Synthase Type III, Single-nucleotide polymorphism, bevacizumab, Polymorphism, Single Nucleotide, 03 medical and health sciences, IL-8, Single nucleotid polymorphisms, Internal medicine, Humans, single nucleotid polymorphisms, Aged, Chemotherapy, business.industry, Interleukin-8, medicine.disease, biology.organism_classification, 030104 developmental biology, Mutation, ras Proteins, business, Pharmacogenetics

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::770b33286ad34b624b58f6efeb235637Test
http://hdl.handle.net/10807/108519Test

المؤلفون: Prisciandaro M., Ratta R., Massari F., Fornarini G., Caponnetto S., Iacovelli R., De Giorgi U., Facchini G., Scagliarini S., Sabbatini R., Caserta C., Peverelli G., Mennitto A., Verzoni E., Procopio G.

المساهمون: Prisciandaro, M., Ratta, R., Massari, F., Fornarini, G., Caponnetto, S., Iacovelli, R., De Giorgi, U., Facchini, G., Scagliarini, S., Sabbatini, R., Caserta, C., Peverelli, G., Mennitto, A., Verzoni, E., Procopio, G.

مصطلحات موضوعية: c-Met, cabozantinib, nonclear cell, renal cell carcinoma, targeted therapy, Administration, Oral, Aged, Anilide, Carcinoma, Renal Cell, Disease-Free Survival, Female, Human, Kidney Neoplasm, Male, Middle Aged, Pyridine, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30204614; info:eu-repo/semantics/altIdentifier/wos/WOS:000458278300008; volume:42; issue:1; firstpage:42; lastpage:45; numberofpages:4; journal:AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS; http://hdl.handle.net/11573/1341170Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85058886805

الإتاحة: https://doi.org/10.1097/COC.0000000000000478Test
http://hdl.handle.net/11573/1341170Test

المؤلفون: Vincenzo Mazzaferro, Massimo Milione, Ilaria Bossi, Alessia Mennitto, Jorgelina Coppa, Federica Perrone, Marta Caporale, Filippo de Braud, Emilio Bajetta, Maria Di Bartolomeo, Christian Cotsoglou, Roberto Iacovelli, Filippo Pietrantonio, Rosa Berenato, Federica Morano, Mauro Scotti, Francesca Ricchini, Alessandra Alessi, Marta Vaiani

المصدر: Clinical Colorectal Cancer. 16:e191-e198

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Organoplatinum Compounds, Colorectal cancer, medicine.medical_treatment, Population, Cetuximab, Kaplan-Meier Estimate, Adenocarcinoma, Irinotecan, Gastroenterology, Disease-Free Survival, Capecitabine, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, education, Aged, education.field_of_study, business.industry, Liver Neoplasms, Middle Aged, medicine.disease, Oxaliplatin, Regimen, 030104 developmental biology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Camptothecin, Female, Neoplasm Recurrence, Local, Hepatectomy, Colorectal Neoplasms, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17d3f49188abd34093f55e315030b79aTest
https://doi.org/10.1016/j.clcc.2016.09.007Test

المؤلفون: Daniele Rossini, Alessia Mennitto, Martin D. Berger, Sabina Murgioni, Satoshi Okazaki, Wu Zhang, Yuji Miyamoto, Afsaneh Barzi, Marta Schirripa, Shu Cao, H. J. Lenz, Mitsukuni Suenaga, Roel Gopez, D. Y. Yang, Toshiharu Yamaguchi, Yan Ning, Fotios Loupakis, Federica Marmorino

المصدر: Annals of Oncology. 28:1015-1022

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Pyrrolidines, Pyridines, Colorectal cancer, Antineoplastic Agents, Single-nucleotide polymorphism, Disease-Free Survival, Trifluridine, 03 medical and health sciences, 0302 clinical medicine, XRCC3, Internal medicine, medicine, Humans, Progression-free survival, CHEK1, Uracil, 610 Medicine & health, CHEK2, Genetic Association Studies, Aged, Proportional Hazards Models, Retrospective Studies, Aged, 80 and over, business.industry, Phenylurea Compounds, Liver Neoplasms, Retrospective cohort study, Original Articles, Hematology, Middle Aged, medicine.disease, Drug Combinations, DNA Repair Enzymes, Treatment Outcome, 030104 developmental biology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Cohort, Female, Colorectal Neoplasms, business, Thymine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5d6c605f4a9a0ff0b1313f82acf0b96Test
https://doi.org/10.1093/annonc/mdx035Test

المؤلفون: Pietrantonio, F, Miceli, R, Rimassa, L, Lonardi, S, Aprile, G, Mennitto, A, Marmorino, F, Bozzarelli, S, Antonuzzo, L, Tamburini, E, Morano, F, Rossini, D, Battaglin, F, Baretti, M, Berenato, R, Formica, V, Mosconi, S, Petrelli, F, Ghidini, M, Loupakis, F, Spada, D, Cinieri, S, Beretta, G, Falcone, A, de Braud, F, Cremolini, C

المساهمون: F. Pietrantonio, R. Miceli, L. Rimassa, S. Lonardi, G. Aprile, A. Mennitto, F. Marmorino, S. Bozzarelli, L. Antonuzzo, E. Tamburini, F. Morano, D. Rossini, F. Battaglin, M. Baretti, R. Berenato, V. Formica, S. Mosconi, F. Petrelli, M. Ghidini, F. Loupaki, D. Spada, S. Cinieri, G. Beretta, A. Falcone, F. de Braud, C. Cremolini

مصطلحات موضوعية: TAS-102, colorectal cancer, nomogram, prognosi, refractory, regorafenib, aged, colon, colorectal neoplasm, disease-free survival, drug combination, female, human, logistic model, male, middle aged, neoplasm metastasi, phenylurea compound, proportional hazards model, pyridine, trifluridine, uracil, cost-benefit analysi, nomograms, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27864220; info:eu-repo/semantics/altIdentifier/wos/WOS:000397300100020; volume:28; issue:3; firstpage:555; lastpage:561; numberofpages:7; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/2434/553673Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85018307237

الإتاحة: https://doi.org/10.1093/annonc/mdw627Test
http://hdl.handle.net/2434/553673Test